Abstract
The test-trace-isolate-quarantine (TTIQ) strategy, where confirmed-positive pathogen carriers are isolated from the community and their recent close contacts are identified and pre-emptively quarantined, is used to break chains of transmission during a disease outbreak. The protocol is frequently followed after an individual presents with disease symptoms, at which point they will be tested for the pathogen. This TTIQ strategy, along with hygiene and social distancing measures, make up the non-pharmaceutical interventions that are utilised to suppress the ongoing COVID-19 pandemic. Here we develop a tractable mathematical model of disease transmission and the TTIQ intervention to quantify how the probability of detecting and isolating a case following symptom onset, the fraction of contacts that are identified and quarantined, and the delays inherent to these processes impact epidemic growth. In the model, the timing of disease transmission and symptom onset, as well as the frequency of asymptomatic cases, is based on empirical distributions of SARS-CoV-2 infection dynamics, while the isolation of confirmed cases and quarantine of their contacts is implemented by truncating their respective infectious periods. We find that a successful TTIQ strategy requires intensive testing: the majority of transmission is prevented by isolating symptomatic individuals and doing so in a short amount of time. Despite the lesser impact, additional contact tracing and quarantine increases the parameter space in which an epidemic is controllable and is necessary to control epidemics with a high reproductive number. TTIQ could remain an important intervention for the foreseeable future of the COVID-19 pandemic due to slow vaccine rollout and highly-transmissible variants with the potential for vaccine escape. Our results can be used to assess how TTIQ can be improved and optimised, and the methodology represents an improvement over previous quantification methods that is applicable to future epidemic scenarios.
Author summary Detecting symptomatically-infected individuals and isolating them from the community is used slow the spread of an infectious disease. Additional contact tracing and quarantine can further interrupt chains of disease transmission. These measures are employed globally to control the ongoing COVID-19 pandemic. Here we use a mathematical model to quantify how effective the test-trace-isolate-quarantine (TTIQ) intervention can be against SARS-CoV-2 spread, and how delays and inaccuracies in these processes can reduce this effectiveness. With this framework we seek to improve and optimise the TTIQ intervention and to understand the problems that we could face with new variants and/or vaccine escape. We show that increasing the detection of new infections, and doing so with minimal delay after symptom onset, is key to an effective intervention.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Swiss National Science Foundation. The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No IRB necessary
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Code is publicly available at http://github.com/ashcroftp/COVID-TTIQ.
Further sensitivity analyses for asymptomatic infections (Appendix S2). Appendix for the role of overdispersion of the contact distribution (Appendix S3). Quadratic terms in the LDA analysis to capture parameter interactions (Figure S4).
Data Availability
Code is publicly available at https://github.com/ashcroftp/COVID-TTIQ
Data Availability
Code is publicly available at https://github.com/ashcroftp/COVID-TTIQ
